| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |